Provided by Tiger Fintech (Singapore) Pte. Ltd.

KINTOR PHARMA-B

2.120
-0.150-6.61%
Volume:5.41M
Turnover:11.68M
Market Cap:948.70M
PE:-5.38
High:2.290
Open:2.260
Low:2.120
Close:2.270
Loading ...

37 New Funds Launch This Week: Targeting STAR Market + Medicine and Other Hot Sectors, with Liu Shiqing, Tian Guangyuan, Deng Mo, En Xuehai and Others in Competition

Deep News
·
04 Aug

A-Share Market Review: Trading Volume Shrinks by Over 300 Billion Yuan, Three Major Indices Close Slightly Lower While Pharmaceutical Stocks Maintain Strength

Stock News
·
01 Aug

112% Returns at Peak Before Sudden Departure? Yongying Fund's Chu Kefan Resignation Sparks Speculation as "Steady Innovation" Strategy Shows Success Only in Healthcare

Deep News
·
01 Aug

Kintor Pharmaceutical Ltd. Announces Top-Up Placing and New Share Subscription Under General Mandate

Reuters
·
01 Aug

BRIEF-Kintor Pharmaceutical To Issue 20.7 MLN Shares For HK$2.08 Per Share

Reuters
·
01 Aug

Kintor Pharmaceutical - to Issue 20.7 Mln Shares for HK$2.08 per Share

THOMSON REUTERS
·
01 Aug

Kintor Pharmaceutical Completes Patient Enrollment for Phase III Trial of KX-826 Tincture for Male AGA Treatment in China

Reuters
·
31 Jul

Kintor Pharmaceutical:Phase Ii Stage of Pivotal Clinical Trial Kx-826 Tincture 1.0% for Treatment of Male Adult Aga in China Reached Primary Endpoint

THOMSON REUTERS
·
25 Jul

Kintor Pharmaceutical's Alopecia Drug Meets Main Goal of Mid-stage Study in China; Shares Rise 3%

MT Newswires Live
·
24 Jul

Kintor Pharmaceutical Announces Positive Phase II Trial Results for KX-826 Tincture in Treating Male AGA in China

Reuters
·
24 Jul

Citi: Sino Biopharm's Acquisition of Lixun Pharmaceutical Marks First China-to-China M&A in Industry; Maintains "Buy" Rating

Deep News
·
16 Jul

Pharmaceutical Sector Surges as Brokerages Rally Behind Innovative Drugs

Deep News
·
16 Jul

Citi: Sino Biopharm's (01177.HK) LaNova Buyout Marks China's First Domestic Biotech M&A; Rates "Buy"

Stock News
·
16 Jul

New Third Board Listings Surge: 158 Companies Added in First Half of 2025

Deep News
·
16 Jul

Morgan Stanley: Sino Biopharmaceutical's (01177) Acquisition of LaNova Medicine Reasonably Priced; HK$4.9 Target Maintained

Stock News
·
16 Jul

Sino Biopharm (01177) Surges Over 5% on $500M Acquisition of Liannovo Pharma with $4B Licensing Portfolio

Market Watcher
·
16 Jul

Sino Biopharmaceutical Surges 5% in Early Trading with $500 Million Acquisition of Shanghai Laixin Pharmaceuticals

Market Watcher
·
16 Jul

Sino Biopharm (01177) Surges Over 5% at Open with $500M Lixin Pharma Acquisition, Total Licensing Deals Near $4B

Stock Track
·
16 Jul

U.S. Stocks Movement: Pharmaceutical Sector Slides, Eli Lilly (LLY.US) Tumbles Over 2.9%

Market Watcher
·
15 Jul

US Stocks Movement | Pharma Sector Declines with Eli Lilly (LLY.US) Down Over 2.9%

Stock Track
·
15 Jul